Format

Send to

Choose Destination
J Huntingtons Dis. 2018;7(1):89-98. doi: 10.3233/JHD-189001.

Huntington’s Disease Clinical Trials Corner: February 2018

Author information

1
Huntington's Disease Centre, University College London, UK.
2
Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal.
3
Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.

Abstract

In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859).

Supplemental Content

Full text links

Icon for IOS Press Icon for PubMed Central
Loading ...
Support Center